Mumbai-based Haffkin Institute has received permission from the Centre on Thursday to manufacture Bharat Biotech’s Covaxin on the basis of transfer of technology.
The owner of the institute, the Maharashtra government thanked PM Modi for the approval and tweeted, “The Dept. Of Science and Technology, Government of India, has granted approval to Haffkin Institute to produce Bharat Biotech’s CovaxinCovaxin vaccine on a transfer of technology basis.”
“CM Uddhav Balasaheb Thackeray has thanked Prime Minister for approving this request,” the tweet from the CM Office added.
Maharashtra is currently among the highest Covid case spike states.
Health: Global Capability Centres Grapple with Unhealthy Gender Ratio Global Capability Centres (GCCs) have emerged…
Autism: The Leading Health Concern Among Global Youth Autism Spectrum Disorder (ASD) is increasingly being…
Chinese Garlic: Did you know that Chinese garlic has been banned in India? This garlic…
Wake Up in Winter: Waking up in the winter mornings can be tough, especially when…
Alert: Did you know that a dangerous disease is killing one person every 33 seconds?…
Top Global Health Stories of 2024: Breakthroughs, Challenges, and Innovations The year 2024 has been…